Top compounds associated with response to GLRX3


Feature Type Standardized
Nominal ANOVA
mRNA ML162 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.01
mRNA Crizotinib FIMM pan-cancer AAC 0.43 0.01
mRNA BIRB 0796 CTRPv2 pan-cancer AAC -0.099 0.01
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.01
mRNA EX-527 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.01
mRNA 17-AAG CCLE pan-cancer AAC 0.12 0.01
Download CSV